Application Sponsors
ANDA 214856 | NANJING KING-FRIEND | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 300MG/3ML (100MG/ML) | 0 | ENOXAPARIN SODIUM | ENOXAPARIN SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-06-14 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
NANJING KING-FRIEND
cder:Array
(
[0] => Array
(
[ApplNo] => 214856
[companyName] => NANJING KING-FRIEND
[docInserts] => ["",""]
[products] => [{"drugName":"ENOXAPARIN SODIUM","activeIngredients":"ENOXAPARIN SODIUM","strength":"300MG\/3ML (100MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/14\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-06-14
)
)